Literature DB >> 1793386

Prognostic validity of brainstem electric response audiometry in infants of a neonatal intensive care unit.

A Durieux-Smith1, T W Picton, P Bernard, B MacMurray, J T Goodman.   

Abstract

This study compared the results of brainstem electric response audiometry (BERA) in infants of a neonatal intensive care unit to those obtained on the same children with pure-tone audiometry at 3 years of age. Six hundred children were initially tested in infancy, and complete follow-up information was obtained on 333. In 297 (89%) the BERA results accurately predicted the hearing status at the age of 3 years. Twenty-nine (9%) of the discrepancies were related to conductive hearing losses: 17 patients with a conductive hearing loss in the first few months of life had normal hearing at 3 years, and 12 patients normal in infancy had a conductive loss at 3 years. Two patients evaluated as a sensorineural hearing loss by BERA had normal hearing. These may have been due to a conductive loss. Six patients assessed as normal by BERA had significant hearing losses at the age of 3 years. Five of these had normal hearing at one frequency between 1,000 and 4,000 Hz. The sixth may have developed a sensorineural hearing loss after birth.

Entities:  

Mesh:

Year:  1991        PMID: 1793386     DOI: 10.3109/00206099109072889

Source DB:  PubMed          Journal:  Audiology        ISSN: 0020-6091


  3 in total

Review 1.  Auditory neuropathy/dys-synchrony and its perceptual consequences.

Authors:  Gary Rance
Journal:  Trends Amplif       Date:  2005

2.  The costs of early hearing screening in England and Wales.

Authors:  J C Stevens; D M Hall; A Davis; C M Davies; S Dixon
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

3.  Clinical comparison of the auditory steady-state response with the click auditory brainstem response in infants.

Authors:  Hyo Sook Lee; Joong Ho Ahn; Jong Woo Chung; Tae Hyun Yoon; Kwang-Sun Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-12-26       Impact factor: 3.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.